drugset / Trial / NCT04572906

Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

NCT04572906 ↗

Phase 2 Completed 51 enrolled Neuraptive Therapeutics Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.

Timeline

Start
2020-09-25
Primary completion
2024-06-27
Completion
2024-06-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject NTX-001 Unknown — Topical